SLC5A2 and hyperinsulinemic hypoglycemia, familial, 4: Most patients with SGLT2 inhibitor-associated euDKA have type 1 diabetes or latent autoimmune diabetes in adults (LADA) or have long-standing insulin deficient type 2 diabetes and develop DKA in the presence of stress and illness [18].